| 분자 | Cat. No. | Product Name | 종 | Host | 구조 | 순도 | Activity | 규격 및 가격 |
|---|---|---|---|---|---|---|---|---|
| TREM-1 | Human TREM-1 / CD354 Protein, Fc Tag, low endotoxin | Human | HEK293 | ![]() | SDS-PAGE | $395.00 100ug |
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| Nangibotide | LR-12 | Phase 2 Clinical | Inotrem | Coronavirus Disease 2019 (COVID-19); Shock, Septic | 상세 |
| ABBV-8736 | ABBV-8736 | Phase 2 Clinical | Abbvie Inc | Crohn Disease; Inflammatory Bowel Diseases | 상세 |
| TREM-1 antibody (Boehringer Ingelheim) | Phase 1 Clinical | Boehringer Ingelheim International Gmbh | Autoimmune Diseases | 상세 | |
| CEL383 | CEL-383 | Phase 1 Clinical | Celsius Therapeutics Inc | Inflammatory Bowel Diseases | 상세 |
| TREM 1 antibody(Boehringer Ingelheim International Gmbh) | TREM 1 antibody(Boehringer Ingelheim International Gmbh) | Phase 1 Clinical | Boehringer Ingelheim International Gmbh | Immune System Diseases | 상세 |
| PY-159 | PY-159 | Phase 1 Clinical | Centre for the Commercialization of Antibodies and Biologics | Neoplasms; Solid tumours | 상세 |